Eppendorf

Unlock the full potential of your pharma/biopharma laboratory with our comprehensive guide on mastering liquid handling techniques for any liquid type.

Unlock the full potential of your pharma/biopharma laboratory with our comprehensive guide on mastering liquid handling techniques for any liquid type.

Unlock the full potential of your pharma/biopharma laboratory with our comprehensive guide on mastering liquid handling techniques for any liquid type.

Unlock the full potential of your pharma/biopharma laboratory with our comprehensive guide on mastering liquid handling techniques for any liquid type.

In this brochure, learn about the Eppendorf Centrifuge CR22N and CR30NX, the everyday centrifuges perfect for a wide range of applications. Read about unique features, technical specifications, common rotor options and more.

This application note describes production of a recombinant protein using a workflow for culturing and harvesting bacteria and purifying proteins. The Eppendorf Centrifuge CR22N or CR30NX is used in combination with the Innova S44i Shaker for a high yield of functional recombinant protein.

This white paper introduces a method for reducing harvesting time of yeast, bacteria, or cell cultures by up to 32% using the Eppendorf Centrifuge CR22N or CR30NX with unique triangular 1.5 L bottles.

Did you know that running costs for a CO2 incubator easily exceed its purchase price over time? Learn how the CellXpert can help you to save money for your lab.

Contamination is associated with experimental repeats and project delays. In this White Paper we discuss the best strategies to prevent contamination in cell culture.

Wednesday October 27th, 2021 at 10am EDT | 7am PDT | 3pm BST | 4pm CEST Antibody products have evolved to be the cornerstone of the biopharmaceutical market and are a driving force in the pharmaceutical landscape. A variety of tools and technologies have contributed to the success and unrivaled growth of antibody products, learn how current and novel technologies may impact antibody product growth in the coming decades.